Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures
Authors:
- 1 December 1999
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (12) , 2561-2568
Abstract
To evaluate the effects of fluoxetine and amitriptyline on nitric oxide (NO), prostaglandin E2 (PGE2), and hyaluronic acid (HA) production in human synovial cells and synovial tissue cultures. Human synovial cells, synovial tissue, and cartilage were cultured in the presence or absence of cytokines, lipopolysaccharides (LPS), fluoxetine, or amitriptyline. Production of NO, PGE2, and HA was determined in culture media. Sulfated glycosaminoglycan (S-GAG) synthesis was evaluated in cartilage by 35S incorporation. Fluoxetine (0.3 μg/ml, 1 μg/ml, and 3 μg/ml) inhibited NO release by 56%, 62%, and 71%, respectively, in the media of synovial cells stimulated by interleukin-1α (IL-1α; 1 ng/ml) plus tumor necrosis factor α (TNFα; 30 ng/ml). Amitriptyline (0.3 μg/ml, 1 μg/ml, and 3 μg/ml) caused a 16%, 27.3%, and 51.4% inhibition of NO release. Fluoxetine and amitriptyline (0.3 μg/ml, 1 μg/ml, and 3 μg/ml) significantly (P < 0.05) inhibited PGE2 release in the media of human synovial cells in the presence of IL-1α plus TNFα, in a dose-dependent manner (up to 88% inhibition). Fluoxetine (0.3 μg/ml, 1 μg/ml, and 3 μg/ml) and amitriptyline (1 μg/ml and 3 μg/ml) significantly (P < 0.05) inhibited PGE2 release in the media of human synovial tissue in the presence of LPS. Fluoxetine and amitriptyline (0.3 μg/ml, 1 μg/ml, and 3 μg/ml) also significantly (P < 0.05) inhibited HA production by human synovial cells in the presence of IL-1β plus TNFα. Fluoxetine and amitriptyline (1 μg/ml) partially reversed IL-1β–induced inhibition of 35S-GAG synthesis by human cartilage cultures (P < 0.05). Neither fluoxetine nor amitriptyline had a toxic effect on cells in the concentrations used. Inhibition of NO and PGE2 production by connective tissue cells is a mechanism by which some antidepressant medications may affect pain, articular inflammation, and joint damage.Keywords
This publication has 34 references indexed in Scilit:
- Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan‐induced inflammationImmunology, 1998
- Pharmacological analysis of cyclooxygenase-1 in inflammationProceedings of the National Academy of Sciences, 1998
- A randomized, double‐blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgiaArthritis & Rheumatism, 1996
- ANTIDEPRESSANT DRUGS AND EXPERIMENTAL INFLAMMATIONPharmacological Research, 1996
- Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.Journal of Clinical Investigation, 1995
- Role of interleukin‐1, tumor necrosis factor α, and interleukin‐6 in cartilage proteoglycan metabolism and destruction effect of in situ blocking in murine antigen‐ and zymosan‐induced arthritisArthritis & Rheumatism, 1995
- Evaluation of amitriptyline in primary fibrositis. A double‐blind, placebo‐controlled studyArthritis & Rheumatism, 1986
- Coping with chronic illness: Strategy preferences, changes in preferences and associated emotional reactionsJournal of Chronic Diseases, 1984
- Connective tissue activation. XXIIn Vitro Cellular & Developmental Biology - Plant, 1981
- Mechanism of inhibition of experimental inflammation by antidepressant drugsEuropean Journal of Pharmacology, 1967